Company profile: GL Chemtec
1.1 - Company Overview
Company description
- Provider of custom small-molecule API discovery, process development, scale-up and manufacturing for life sciences; tailored biomedical polymers and hydrogels for drug delivery and medical devices (including silicone hydrogels, functionalized biopolymers, emulsions, synthetic organoids); integrated drug-delivery solutions combining small-molecule chemistry and polymer design; and analytical method development and transfer, stability studies and sample analysis.
Products and services
- Integrated Solutions: Architects modular systems combining small molecule chemistry with tailored polymer architectures to develop drug delivery technologies and medical device applications, enhancing solubility and bioavailability of drug compounds
- Small Molecule API Development: Engineers custom-engineered processes for discovery, process development, scale-up, and production of small molecule APIs for the life sciences sector
- Tailored Biomedical Polymers: Develops custom-formulated biomedical polymers and hydrogels—silicone hydrogels, functionalized biopolymers, emulsions, synthetic organoids—for drug delivery and medical device applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to GL Chemtec
DynaKin
HQ: Spain
Website
- Description: Provider of contract research services featuring a GLP biolab, model-based drug development, GCP clinical trial design and execution, and product-oriented R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DynaKin company profile →
Network Partners
HQ: United States
Website
- Description: Provider of professional services and life sciences professionals to medical device, pharmaceutical, and biopharmaceutical industries, with core competencies in Regulatory Affairs, Medical Writing, Packaging Engineering, Labeling, Quality, and Project Management to help clients complete the work necessary to deliver products to patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Network Partners company profile →
Minafin
HQ: France
Website
- Description: Provider of fine chemicals for life sciences and high tech, developing and manufacturing active ingredients, organic intermediates, and specialty chemicals. Offers APIs (patented, generic, HPAPIs), cosmetic and agricultural ingredients, bio-based solvents and fine chemicals, highly reactive chemistry for complex synthesis, process scale-up, high-pressure chemistry, and niche polymers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minafin company profile →
Dalton Pharma Services
HQ: Canada
Website
- Description: Provider of cGMP contract drug discovery, development, and manufacturing services to pharmaceutical and biotechnology industries. FDA-registered and Health Canada approved with over 30 years of experience. Offerings include cGMP API manufacturing, custom chemical synthesis, formulation development, sterile filling services, accelerated stability testing, and conjugation services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dalton Pharma Services company profile →
Metrion Biosciences
HQ: United Kingdom
Website
- Description: Provider of specialist ion channel contract research for drug discovery to pharmaceutical and bioscience customers worldwide, including validated ion channel screening, CiPA-compliant human cardiac ion channel assays (GLP hERG), neuroscience ion channel and neurotoxicology screening, translational phenotypic assays, integrated ion channel research programs, and HTS for hit finding, lead optimization, and selectivity profiling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metrion Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for GL Chemtec
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to GL Chemtec
2.2 - Growth funds investing in similar companies to GL Chemtec
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for GL Chemtec
4.2 - Public trading comparable groups for GL Chemtec
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →